Canopy Partners LLC Grows Stake in Roche Holding AG (OTCMKTS:RHHBY)

Canopy Partners LLC grew its holdings in shares of Roche Holding AG (OTCMKTS:RHHBYFree Report) by 4.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,772 shares of the company’s stock after purchasing an additional 344 shares during the period. Canopy Partners LLC’s holdings in Roche were worth $310,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. SVB Wealth LLC boosted its stake in Roche by 2.6% in the 1st quarter. SVB Wealth LLC now owns 16,646 shares of the company’s stock worth $531,000 after purchasing an additional 426 shares in the last quarter. Hancock Whitney Corp raised its holdings in shares of Roche by 2.4% in the first quarter. Hancock Whitney Corp now owns 28,995 shares of the company’s stock worth $926,000 after buying an additional 678 shares during the last quarter. Confluence Investment Management LLC lifted its stake in shares of Roche by 3.7% during the second quarter. Confluence Investment Management LLC now owns 12,922 shares of the company’s stock worth $448,000 after buying an additional 459 shares during the period. GAMMA Investing LLC grew its holdings in shares of Roche by 61.5% during the second quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock valued at $175,000 after buying an additional 1,919 shares during the last quarter. Finally, Cardinal Capital Management Inc. acquired a new position in shares of Roche in the 2nd quarter valued at $16,860,000.

Analyst Ratings Changes

Several analysts have weighed in on RHHBY shares. Bank of America upgraded Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Deutsche Bank Aktiengesellschaft lowered Roche from a “hold” rating to a “sell” rating in a research report on Friday, September 13th. Three research analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, Roche presently has an average rating of “Hold”.

View Our Latest Stock Analysis on Roche

Roche Stock Up 0.4 %

OTCMKTS:RHHBY opened at $35.44 on Friday. The firm’s fifty day moving average is $38.61 and its two-hundred day moving average is $37.27. Roche Holding AG has a one year low of $29.20 and a one year high of $42.43.

About Roche

(Free Report)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

Further Reading

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.